Abstract
Due to the insufficient supply of embryonated chicken eggs, the preparation of large quantities of inactivated influenza vaccines will require an alternative virus culture system after the emergence or reemergence of a pandemic influenza virus. The Vero cell is one of the ideal options since it was used for producing many kinds of human vaccines. However, most of the influenza viruses can not grow well in Vero cells. To develop a new influenza vaccine with Vero cells as a substrate, the virus needs to adapt to this cell substrate to maintain high growth characteristics. By serial passages in Vero cells, the B/Yunnan/2/2005va (B) strain was successfully adapted to Vero cells, with the hemagglutination titer (HAT) of the virus reaching 1:512. The high growth characteristic of this strain is stable up to 21 passages. The strain was identified by hemagglutination inhibition (HAI) test and sequencing respectively; the HA1 gene sequence of the virus was cloned and analyzed. The screening and establishment of high growth B virus provides an important tool for influenza vaccine production in Vero cells.
Key words: Influenza B Virus, Vero Cells, Adaption
Footnotes
Foundation items: National “863 Project” (2006AA02Z409); National health project (200802023); Yunnan sciences and technology cooperation (2006XY29)
Contributor Information
Jing-si Yang, Phone: +86-871-83334986, Email: yjs@imbcams.com.cn.
Chang-gui Li, Phone: +86-10-67095426, Email: changguili@yahoo.com.cn.
Reference
- 1.Audsley J. M., Tannock G. A. Cell-Based Influenza Vaccines. Drugs. 2008;68(11):1483–1491. doi: 10.2165/00003495-200868110-00002. [DOI] [PubMed] [Google Scholar]
- 2.Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007;25:6852–6862. doi: 10.1016/j.vaccine.2007.07.027. [DOI] [PubMed] [Google Scholar]
- 3.Chen J. M., Guo Y. J., Wu K. Y., et al. Two pedigree and the origin of influenza B virus evolution. Chin J Virol. 2001;17(4):322–327. [Google Scholar]
- 4.Govorkova E. A., Murti G., Meignier B., et al. African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J Virol. 1996;70(8):5519–55241. doi: 10.1128/jvi.70.8.5519-5524.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Jackson D., Cadman A., Zurcher T., et al. A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA. J Virol. 2002;76:11744–117471. doi: 10.1128/JVI.76.22.11744-11747.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lu J. P., Zhou R., Ou Z. Y., et al. Isolate the Guangdong strain of influenza B virus and analyzed it’s HA gene fragments. Guangdong Med Sci. 2008;7(29):1120–1122. [Google Scholar]
- 7.Poland G. A., Rottinghaus S. T., Jacobson R. M. Influenza vaccines: a review and rationale for use in developed and underdeveloped countries. Vaccine. 2001;19:2216–2220. doi: 10.1016/S0264-410X(00)00448-5. [DOI] [PubMed] [Google Scholar]
- 8.Qi L., Wu K. Y., Li X., et al. Screen for high yield influenza B virus in MDCK cells and cloned the whole genome. Chin J Virol. 2004;20(3):195–199. [Google Scholar]
- 9.Robertson J. S. An overview of host cell selection. Dev Biol Stand. 1999;98:7–11. [PubMed] [Google Scholar]
- 10.Simonsen L., Taylor R. J., Viboud C., et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infectious Disease. 2007;7:658–666. doi: 10.1016/S1473-3099(07)70236-0. [DOI] [PubMed] [Google Scholar]
- 11.Wu S. H., Shu Y. L. The application perspective of the influenza vaccine in Vero cells. Chin J Virol. 2006;22(1):70–73. [Google Scholar]
- 12.Zhao B. X., Li Y., He W. Y., et al. Compared two cells strains sensitive to influenza virus. Chin J Disinfec. 2008;5(25):463–465. [Google Scholar]